Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation, Restricted Stock and Stock Options

v3.23.1
Stock-Based Compensation, Restricted Stock and Stock Options
3 Months Ended
Mar. 31, 2023
Stock-Based Compensation, Restricted Stock and Stock Options [Abstract]  
Stock-Based Compensation, Restricted Stock and Stock Options

Note 13 - Stock-Based Compensation, Stock Options, Restricted Stock Units and Warrants:

 

On December 22, 2022, the Company adopted its 2022 Long-Term Incentive Plan (the “2022 Plan”). Under the 2022 Plan, there are 4,200,000 shares of the Company’s common stock available for issuance and the 2022 Plan has a termination date of October 31, 2032.

 

The available shares in the 2022 Plan will automatically increase on the first trading day in January of each calendar year during the term of 2022 Plan, commencing with January 2023, by such number of shares of common stock as are necessary so that the total number of shares reserved for issuance under the 2022 Plan shall be equal to 19.9% of the total number of outstanding shares of common stock, determined on a fully diluted basis as of the applicable trading date (the “Stipulated Percentage”); (b) our Board of Directors may act prior to January 1st of a given calendar year to provide that (i) there will be no such automatic annual increase in the number of shares reserved for issuance under the 2022 Plan or (ii) the increase in the number of shares for such calendar year will be a lesser number of shares than necessary to maintain the Stipulated Percentage of shares reserved for issuance under the 2022 Plan; and (c) unless an increase in shares reserved for issuance under the 2022 Plan in excess of the Initial Share Limit has been approved by our shareholders, the maximum number of shares of common stock that may be delivered pursuant to incentive stock options shall not exceed the Initial Share Limit or, if greater, the number of shares of common stock subsequently approved by the requisite vote of our shareholders entitled to vote thereon.

 

On December 16, 2020, the Company adopted its 2020 Long-Term Incentive Plan (the “2020 Plan”). Under the 2020 Plan, there are 5,333,333 shares of the Company’s common stock available for issuance and the 2020 Plan has a term of 10 years. The available shares in the 2020 Plan will automatically increase on the first trading day in January of each calendar year during the term of this Plan, commencing with January 2021, by an amount equal to the lesser of (i) five percent (5%) of the total number of shares of common stock issued and outstanding on December 31 of the immediately preceding calendar year, (ii) 1,000,000 shares of common stock or (iii) such number of shares of common stock as may be established by the Company’s Board of Directors.

 

The Company grants equity-based compensation under its 2020 Plan and its 2016 Equity Incentive Plan (the “2016 Plan”). The 2020 Plan and 2016 Plan allows the Company to grant incentive and nonqualified stock options, and shares of restricted stock to its employees, directors and consultants. On June 14, 2019, the Board of Directors of the Company approved increasing the number of shares allocated to the Company’s 2016 Equity Incentive Plan from 5,500,000 to 7,333,333.

 

Under the 2016 Plan and the 2020 Plan, upon the exercise of stock options and issuance of fully vested restricted common stock, shares of common stock may be withheld to satisfy tax withholdings. The Company intends to net settle certain employee options to ensure adequate authorized shares under the Incentive Plan.

 

Stock-based compensation:

 

The Company recognized total expenses for stock-based compensation during the three months ended March 31, 2023 and 2022, which are included in the accompanying statements of operations, as follows (in thousands):

 

    Three months ended
March 31,
 
    2023     2022  
    (Unaudited)     (Unaudited)  
Research and development expenses   $ 59     $ 55  
Selling, general and administrative expenses     122       1,028  
Total stock-based compensation   $ 181     $ 1,083  

 

Stock Options:

 

The Company provides stock-based compensation to employees, directors and consultants under both the 2016 and 2020 Plans. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option pricing model. The Company historically has been a private company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The risk-free interest rate is determined by referencing the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.

 

A summary of activity under the 2016 and 2020 Plans for the nine three months ended March 31, 2023 is as follows:

 

    Shares
Underlying
Options
    Weighted
Average
Exercise
Price
    Weighted Average
Remaining
Contractual
Term (Years)
    Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2022     9,513,624     $ 2.64       6.5     $ 26,188  
Forfeited     (90,138 )   $ 3.29      
-
         
Outstanding at March 31, 2023     9,423,486     $ 2.63       6.3     $
-
 
                                 
Exercisable at March 31, 2023     8,521,662     $ 2.80       6.0     $
-
 

 

Restricted stock units:

 

A summary of the Company’s restricted stock activity during the three months ended March 31, 2023 is as follows:

 

    Number of
Shares
    Weighted Average
Grant-Date
Fair Value
 
Unvested at January 1, 2023     628,780     $ 1.37  
Vested     (130,867 )   $ 1.55  
Unvested at March 31, 2023     497,913     $ 1.32  

 

Warrants:

 

A summary of the Company’s warrant (excluding penny warrants) activity during the three months ended March 31, 2023 is as follows:

 

    Shares
Underlying
Warrants
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term (Years)
    Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2022     27,661,181     $ 0.75       4.5     $
      -
 
Issued     14,764,258     $ 0.32       4.7      
 
 
Exercised     (6,405,844 )   $ 0.32      
-
     
 
 
Outstanding at March 31, 2023     36,019,595     $ 0.65       4.4     $
-
 

 

2023 Liability Classified Warrants

 

Senior Secured Note

 

During the three months ended March 31, 2023, in connection with the issuance of its senior secured notes on January 3, 2023 (See Note 11), the Company issued 2,500,000 warrants to purchase shares of the Company’s common stock with an exercise price of $0.32 per share. The warrants expire 5 years from the issuance date.

 

Line of Credit

 

During the three months ended March 31, 2023, in connection with its Line of Credit, the Company issued 45,000 warrants to purchase shares of its Series E preferred stock with an exercise price of $0.50 per share multiplied by 1,000, and subject to adjustment under certain circumstances described in the warrant. (See Note 12). The warrants expire 5 years from the issuance date.

 

2022 Notes

 

During the year ended December 31, 2022, in connection with the 2022 Notes, the Company issued 21,759,402 warrants to purchase shares of the Company’s common stock. The warrants have an exercise price of $0.32 per share and expire five years from the issuance date.

 

During the three months ended March 31, 2023, in connection with its 2022 Notes, the Company entered into a warrant inducement and exercise agreement with certain holders. Under the terms of the agreement, the holders exercised 6,405,844 warrants, and the Company issued 6,405,844 new warrants to purchase shares of its common stock with an exercise price of $0.32 per share. The warrants expire 5 years from the issuance date.

 

On February 28, 2023, the Company entered into waiver agreements with holders of the 2022 Notes and issued 5,813,414 warrants to purchase shares of the Company’s common stock with an exercise price of $0.32 per share.

 

2022 Equity Classified Warrants

 

Hudson Pacific Properties, L.P.

 

On August 12, 2022, the Company entered into two Purchase Orders (PO’s) with Hudson Pacific Properties, L.P. (“Hudson”) for the purchase of the Company’s Smart Window Inserts™ (“Inserts”). Hudson is a unique provider of end-to-end real estate solutions for tech and media tenants. The PO’s have a value of $85,450 and represent the first orders the Company has received prior to the launch of its Inserts. Delivery and installation are expected to begin in the fourth quarter of 2023.

 

On August 12, 2022, as additional consideration for the PO’s, the Company issued a warrant to Hudson to purchase 300,000 shares of the Company’s common stock at $0.75 per share. The warrant has a five-year life and expires on August 12, 2027.

 

Because Hudson is a customer, the Company accounts for the PO’s and warrants under Accounting Standards Codification (“ASC”) 606 Revenue Recognition (“ASC 606”). As the performance obligations have not yet been satisfied, the Company has not recognized any revenue during the three months ended March 31, 2023.

 

The Company accounts for the equity-classified warrant as consideration payable to a customer under ASC 606, as it relates to the future purchase of the Inserts. Pursuant to ASC 718 Compensation - Stock Compensation (“ASC 718”), the Company measured the fair value of the warrant using the Black-Scholes valuation model on the issuance date, with the value being recognized as a prepaid asset up to the recoverable value represented by the value of the contract. The fair value of the warrant on the issuance date totaled $161,700, and as of March 31, 2023 and December 31, 2022, the Company recorded a prepaid asset of $85,450, representing the recoverable value from the PO’s, which is included in prepaid and other current assets on the accompanying consolidated balance sheet.

 

SLOC

 

In connection with the SLOC, on March 17, 2022 the Company issued a warrant for 200,000 shares of common stock with an exercise price of $2.00, and a total fair value of approximately $223,000. This amount is included in the accompanying consolidated balance sheet as deferred debt issuance costs (See Note 6).